Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Flour × Clear all

Phase

Status

Completed 3 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Insulin Resistance 1 Hypoglycemia 1

Interventions

Cyclophosphamide 343 Carboplatin 290 pembrolizumab 273 Gemcitabine 272 Cisplatin 266 Radiotherapy 257 Paclitaxel 254 Docetaxel 249 Bevacizumab 216 Rituximab 202 Capecitabine 193 Nivolumab 183 Dexamethasone 173 Fluorouracil 171 fludarabine 157 Oxaliplatin 150 Doxorubicin 137 Leucovorin 128 Irinotecan 128 Pemetrexed 123 Etoposide 123 Cytarabine 122 fludarabine phosphate 112 Bortezomib 111 Lenalidomide 108 Cetuximab 107 Filgrastim 106 Erlotinib Hydrochloride 100 Temozolomide 96 Radiosurgery 95

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00970541 2021-08-25

Eccentric

Pennington Biomedical Research Center

Phase 1 Terminated

Hypoglycemia, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡